Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program

Olga V. Leontieva, Zoya N. Demidenko, and Mikhail V. Blagosklonny
  1. Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263

See allHide authors and affiliations

PNAS June 17, 2014 111 (24) 8832-8837; first published June 2, 2014; https://doi.org/10.1073/pnas.1405723111
Olga V. Leontieva
Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zoya N. Demidenko
Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mikhail V. Blagosklonny
Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: blagosklonny@oncotarget.com
  1. Edited by Peter K. Vogt, The Scripps Research Institute, La Jolla, CA, and approved May 9, 2014 (received for review March 31, 2014)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

This work solves longstanding mysteries in the field of contact inhibition (CI), cancer, and aging. As shown here during CI, cells do not undergo senescence, thus resuming proliferation after replating. We found that CI was associated with inhibition of the mammalian target of rapamycin (mTOR) pathway, which is required for the senescence program. In cancer cells, lacking CI, mTOR was still inhibited in high cell density by an alternative mechanism. Our work explains why CI is reversible and how cells can avoid senescence in vivo, allowing the organism to last for decades. Implications for cancer therapy are discussed.

Abstract

During cell cycle arrest caused by contact inhibition (CI), cells do not undergo senescence, thus resuming proliferation after replating. The mechanism of senescence avoidance during CI is unknown. Recently, it was demonstrated that the senescence program, namely conversion from cell cycle arrest to senescence (i.e., geroconversion), requires mammalian target of rapamycin (mTOR). Geroconversion can be suppressed by serum starvation, rapamycin, and hypoxia, which all inhibit mTOR. Here we demonstrate that CI, as evidenced by p27 induction in normal cells, was associated with inhibition of the mTOR pathway. Furthermore, CI antagonized senescence caused by CDK inhibitors. Stimulation of mTOR in contact-inhibited cells favored senescence. In cancer cells lacking p27 induction and CI, mTOR was still inhibited in confluent culture as a result of conditioning of the medium. This inhibition of mTOR suppressed p21-induced senescence. Also, trapping of malignant cells among contact-inhibited normal cells antagonized p21-induced senescence. Thus, we identified two nonmutually exclusive mechanisms of mTOR inhibition in high cell density: (i) CI associated with p27 induction in normal cells and (ii) conditioning of the medium, especially in cancer cells. Both mechanisms can coincide in various proportions in various cells. Our work explains why CI is reversible and, most importantly, why cells avoid senescence in vivo, given that cells are contact-inhibited in the organism.

When cells are deprived of serum growth factors, they cease proliferation and rest in a reversible state known as quiescence. Conversely, cells undergo senescence, when their cell cycle is arrested in the presence of growth stimulation (1⇓⇓⇓–5). Recently, it was demonstrated that the difference between reversible quiescence and irreversible senescence is determined by an active mammalian target of rapamycin (mTOR) pathway in senescent cells (6⇓⇓⇓⇓–11). When cell cycle is arrested and mTOR is stimulated by serum growth factors or oncoproteins such as Ras, the arrested cells undergo senescence (1, 4, 12, 13). The conversion from reversible cell cycle arrest to senescence is named gerogenic conversion (or geroconversion) (12). Conditions that inhibit mTOR (6, 14, 15) also inhibit geroconversion while causing or maintaining cell cycle arrest (6, 7, 10).

Of note, in cell culture, quiescence and senescence are observed at low or regular cell density. There is a third type of cell cycle arrest. When normal cells reach high density (HD), they stop proliferation [i.e., contact inhibition (CI)] and can stay arrested for weeks. However, when the culture is split and replated, the cells restart proliferation. This condition resembles quiescence, even though it occurs in the presence of growth stimulation by serum. Perhaps CI is the most important and physiological type of cell cycle arrest. First, most cells in the organism are contact inhibited. Like in confluent cell culture, wounding causes cells to restart proliferation and to fill the wound. Second, the most noticeable difference between normal and cancer cells in culture is the lack of CI in cancer cells (16, 17). Cancer cells continue to proliferate, acidifying culture medium and damaging themselves (18).

Whether CI is reversible and why it is reversible remain unknown. Irreversible senescence is characterized by active mTOR pathway, high metabolism, and large flat cell morphology (8, 19⇓–21). In contrast, contact-inhibited cells are characterized by a small vertical morphology and low protein synthesis and metabolism. We speculated that mTOR might be inhibited in high cell density. This would explain the peculiarity of CI. This further would predict that CDK inhibitors, which cause cell senescence at low and regular cell density, would not cause it at HD. Here we tested this hypothesis.

Results

CI Suppresses mTOR and Causes Reversible Arrest.

First, we plated normal retinal pigment epithelium (RPE) cells at regular density (RD) and HD. After 6 d, cells plated at RD reached subconfluency (Fig. 1A, RD), whereas the cells plated at HD became “packed,” i.e., were completely contact-inhibited (Fig. 1A, HD). Contact inhibited cells are typically characterized by positive β-gal staining (22⇓⇓⇓⇓⇓⇓⇓⇓–31). β-Gal staining is not only a hallmark of senescence but also of CI and serum starvation because all three conditions are associated with lysosomal activation (22⇓⇓⇓⇓⇓⇓⇓⇓⇓⇓–33). Importantly, pS6, a marker of the mTOR activity, was undetectable in contact-inhibited cells (Fig. 1B). Contact-inhibited cells retained replicative potential (RP), meaning that the cells restarted proliferation after splitting of the culture (Fig. 1C). This indicated that CI was a reversible condition. In agreement, contact-inhibited cells were arrested in G1 phase as shown by flow cytometry (Fig. 1D). After splitting of the culture, cells reentered the cell cycle, so that 60% of cells were in S-phase after 24 h. Cells progressed to normal cell cycle distribution by 48 h (Fig. 1D). Similarly, human WI38t fibroblasts retained RP during CI, which was associated with decreased S6 phosphorylation (Fig. 1 E–G).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Characterization of reversible CI of normal cells. (A) β-Gal staining. RPE cells were plated at 1 million (HD) and 100,000 (RD) per well in six-well plates. After 6 d in culture, cells were packed in wells plated at 1 million (HD) and were confluent (with some spaces in monolayers) in wells plated at 100,000 (RD). (B) Immunoblot analysis. RPE cells were plated at RD and HD (A) and lysed after 6 d in culture. (C) RP: RPE cells were plated at RD and HD (A) and, after 6 d in culture, cells were split and replated at LD to regrow. After 8 d, cells were counted. (D) Cell cycle distribution: RPE cells were plated at HD and analyzed after 6 h (6 h initial condition) and 6 d in culture by flow cytometry. In parallel, a 6-d culture was replated at LD and cell cycle distribution was analyzed after 24 h and 48 h in culture. (E) β-gal staining. WI38t cells were plated at HD and RD in six-well plates. After 6 d in culture, cells were packed in wells plated at HD and were confluent (with some spaces in monolayers) in wells plated at RD. (F) Immunoblot analysis: WI38t cells were plated at RD and HD (A) and lysed after 6 d in culture. (G) RP: WI38t cells were plated at RD and HD (E) and, after 6 d in culture, cells were split and replated at LD and allowed to regrow. After 7 d, cells were counted.

p27 Induction Is Associated with mTOR Inhibition.

We next investigated the relationship between cell density, p27 induction, and phosphorylation status of S6. RPE cells were plated at increasing cell densities and incubated for 2 d. Levels of p27, a marker of CI (34⇓⇓⇓⇓⇓–40), were progressively increased with increasing cell density. pS6 became undetectable at the higher cell densities (Fig. 2A), i.e., when plated at 2 × 105 per well in a 12-well plate and 4 × 105 per well in a 24-well plate.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Inhibition of the mTOR pathway in CI associated with p27 induction. (A) Immunoblot analysis: RPE cells were plated at a range of densities (shown from highest to lowest) and lysed after 2 d in culture. (B and C) Immunoblot analysis: RPE cells (B) and WI38t cells (C) were plated at HD and lysed on the days indicated. (D) Immunoblot analysis: IEC18 (rat intestinal epithelial) cells were plated at HD and RD. After 4 d, cells were lysed. In a parallel set, culture media were changed to fresh medium for 1 h before lysis (Med Δ). (E) RPE and IEC18 cells were plated at HD. After 2 d in culture, one set of cells was lysed and a second set was replated at LD into fresh medium (marked as “F”) or CM collected from the respective HD culture. At 24 h after replating, cells were lysed for immunoblotting. (F) Immunofluorescence: RPE cells were grown in colonies and stained for p-S6. Cells were photographed under light and fluorescence microscopes.

Next we determined the time course of p27 induction and S6 dephosphorylation in several cell lines (Fig. 2 B–D). At the time of plating (day 0), the Akt/mTOR pathway was activated in RPE cells (Fig. 2B). By day 2, p27, a marker of CI, was induced. At that time, S6 became dephosphorylated and phosphorylation of Akt S473 was decreased. Noteworthy, p53 was not changed (Fig. 2B). Similar results were obtained in human fibroblast WI38t cells, in which p27 was strongly induced by day 2 and phospho-AKT and pS6 became undetectable at that time (Fig. 2C). p53 was not changed. Thus, we observed that the appearance of p27 coincided with dephosphorylation of S6 and AKT. Also, in normal human bladder cells (NBCs), pS6 was decreased at the cell density when p27 was induced (Fig. S1A). We also determined that the Akt/mTOR pathway was inhibited in contact inhibited rat intestinal epithelial IEC18 cells (Fig. 2D).

The change of the medium did not activate the Akt/mTOR pathway in IEC18 cells, suggesting that CI rather than medium conditioning/exhaustion was responsible for mTOR deactivation in this cell line. We also investigated the effect of conditioned medium (CM) from high-density cultures on S6 phosphorylation in the cells plated at RD. We found that CM, even collected from 2–3-wk-old contact-inhibited cultures only marginally (not completely) decreased pS6 level in cells from RD culture (Fig. S1B).

We next used a very sensitive method to detect the effect of CM on the activity of mTOR. Contact-inhibited cells (with undetectable pS6) were replated at regular cell density into fresh medium or into their own CM (Fig. 2E). We found that both p-S6 kinase (T389) and p-S6 were reactivated even when cells were split into CM (Fig. 2E). However, this reactivation was higher in fresh medium than in CM, because mTOR is regulated by numerous medium factors (nutrients, hormones, and mitogens, which may be at higher levels in fresh medium).

Finally, we determined the pattern of S6 dephosphorylation in RPE cells growing as separate dense colonies. As shown in Fig. 2F and Fig. S2, the cells were preferentially negative for pS6 in the middle of the colonies, whereas, at the edges, all cells were pS6-positive. This supports the conclusion that it is the CI rather than conditioning of the medium that is predominantly responsible for mTOR deactivation in normal cells from confluent cultures.

We next investigated whether stimulation of mTOR would convert CI into cellular senescence. To this end, we used lentivirus expressing TSC2 shRNA (shTSC2), which, as we previously described, decreased the levels of TSC2, thus activating mTOR (41, 42). Here we infected RPE and IEC18 cells and then plated them at high cell density to cause CI. After 4 d, the cells were replated at low cell density to determine if cells become senescent. In control, contact inhibited RPE and IEC18 cells (infected with empty vector) regrew after splitting (Fig. 3A). shTSC2-infected cells did not resume proliferation after replating at low density (LD; Fig. 3A), shTSC2-infected contact-inhibited cells acquired large-cell morphology when replated at LD (Fig. 3B). They retained β-gal positivity, which is typical for CI and senescence, even though they were no longer contact-inhibited (solitary cells). Control cells in contrast become β-gal–negative. Also, some shTSC2-infected cells displayed senescence-associated heterochromatin foci (Fig. S3), an additional marker of senescence.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Effect of shTSC2 on senescence of contact-inhibited cells. RPE (A) and IEC18 (B) cells were infected with lentivirus pLKO vector or pLKO-shTSC2 and then were plated at HD. After 4 d, cells were replated at LD and allowed to grow. RP was determined by fold increase in cell number after replating: RPE cells were counted after 8 d of regrowth, and IEC18 cells were counted after 3 d of regrowth. Replicate sets of replated RPE and IEC18 cells were stained for β-gal after 3 d of regrowth. Percentage of senescent cells was determined by counting β-gal–positive cells in three separate fields. Data presented as mean ± SD. (Scale bar: 100 µm.)

High Cell Density Prevents p21-Induced Senescence.

We next investigated whether mTOR inhibition in high cell density can prevent cellular senescence caused by senescence-inducing agents. As described previously, induction of ectopic p21 causes cellular senescence in HT-p21 cells (5, 43⇓–45). In these cells, addition of isopropyl-thio-galactosidase (IPTG) induces p21, causing cell cycle arrest and irreversible senescence, meaning that the cells cannot restart proliferation when IPTG is removed. Here HT-p21 cells were plated at increasing cell densities and treated with IPTG for 3 d (Fig. 4A). After 3 d, cells were trypsinized and replated at very LD: 1,000 viable cells per well (six-well plate). After 8 d in culture formed colonies were stained and counted (Fig. 4A). A number of colonies (which corresponded to a number of nonsenescent cells, i.e., replication-competent cells) increased when cells were treated with IPTG at HD. A number of nonsenescent cells (colonies) increased from 4.7% to 25.8%, when the plating cell density was increased from 50,000 to 1,000,000 cells per well (Fig. 4A). Therefore, IPTG did not cause senescence in dense cultures. However, IPTG still induces p21 in dense cultures. So, the conversion from cell cycle arrest to cellular senescence (geroconversion) was suppressed in HD.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Effects of high-density and CM on p21-induced senescence in HT-p21 cells. (A) Effect of cell density on senescence in HT-p21 cells. RP: HT-p21 cells were treated with IPTG at different densities (as indicated). After 3 d, cells were trypsinized, and 1,000 viable cells were replated in fresh medium without IPTG. Colonies were stained after 8 d. Number of colonies is presented as percentage of 1,000 seeded cells ± SD. (B) β-Gal staining: CM was collected from HT-p21 cells growing for 3 d at LD (CM-LD, 10,000 per well in a six-well plate) or HD (CM-HD, 1,000,000 per well in a six-well plate). Then, HT-p21 cells were plated at LD and treated with IPTG in CM-HD or CM-LD. After a 3-d treatment, cells were stained for β-gal. Percentage of senescent cells was determined by counting β-gal–positive cells in three separate fields. Data presented as mean ± SD. (Scale bar: 100 µm.) (C) Immunoblot analysis: HT-p21 cells in RD were treated with IPTG, when indicated, in fresh medium or CM-HD (CM-HD collected from HD culture of HT-p21 cells after 1 d and 2 d in culture) and lysed 24 h later. I, IPTG 50 µg/mL; R, rapamycin 500 nM.

We next investigated whether CM from HD cultures can inhibit IPTG-induced senescence in HT-p21 cells. HT-p21 cells were placed in CM collected from LD and HD cultures (CM-LD and CM-HD, respectively) and treated with IPTG. CM-HD, but not CM-LD, prevented senescent morphology of HT-p21 cells (Fig. 4B). Consistently, CM-HD inhibited pS6 in freshly plated cells at RD (Fig. 4C), whereas it did not prevent induction of p21 (Fig. 4C). Neither rapamycin nor CM prevented p21 induction and p21-dependent cell cycle arrest (41, 42, 45⇓–47). mTOR is not needed for arrest. However, it is needed for geroconversion from cell cycle arrest to irreversible senescent phenotype (12). Rapamycin and CM inhibited mTOR and thus inhibited geroconversion (i.e., conversion from reversible arrest to senescence). Therefore, inhibition of mTOR does not prevent p21-mediated arrest but it prevents the final step: geroconversion. Although it does not affect p21 expression, inhibition of mTOR prevents the senescent program.

Given that inhibition of mTOR by any means suppresses geroconversion of IPTG-treated HT-p21 cells, this inhibition could account for senescence-inhibiting properties of CM-HD. We confirmed this finding in two additional cancer cell lines. Like in HT-p21 cells, p27 was not detected in high cell density cultures of MCF7 and RKO cells, yet the Akt/mTOR pathway was inhibited (Fig. S1 C and D). The change of the media reactivated the pathway (Fig. S1 C and D). Thus, in cancer cells lacking CI, mTOR is still inhibited at high cell density as a result of conditioning of medium.

CI Suppresses Senescent Program.

Cancer cells do not undergo CI. To imitate the conditions of CI, a very small number of HT-p21 cells was trapped among contact-inhibited RPE cells. (RPE cells exert strong CI without conditioning the medium.) The same small number of HT-p21 cells were plated without RPE cells, as a regular culture condition (Fig. 5). HT-p21 cells express GFP and therefore could be distinguished from RPE cells under fluorescence microscopy. We treated cells with IPTG for 3 d.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

CI of cancer HT-p21 cells in confluent cultures of RPE cells prevents IPTG-induced senescence. (A) HT-p21 cells express GFP and can be distinguished from RPE cells under fluorescence microscopy. HT-p21-9 cells were plated at LD alone (regular culture) or together with HD RPE cells (number of plated HT-p21 cells was ∼5% of the number of RPE cells, i.e., 2,500:50,000; CI, culture) and treated with IPTG. After 3 d, cells were fixed and stained for pS6. Cells were photographed under a fluorescence microscope. (B–D) A small number of HT-p21 cells were plated together with a high number of RPE cells as in A and treated with IPTG. After 3 d, cells were trypsinized and replated: One thousand HT-p21 cells were plated per well in six-well plates. (B) On day 1, green (HT-p21) cells were photographed. (C) RP: after 7 d, green cells were counted. Data are presented as fold increase in number of HT-p21 (green) relative to initially plated numbers. (D) After 7 d, cells were photographed under light and fluorescence microscopes. Overlaid images display green colonies of HT-p21 cells on the top of nonfluorescent monolayer of RPE cells. (E–G) HT-p21 cells were plated and treated with IPTG in regular culture (alone) or together with RPE cells (CI culture) as in B–D. After 3 d, treatment cells were sorted for GFP by using flow cytometry, and green cells were plated at 500 per well in 12-well plates in drug-free medium. Colonies were allowed to grow for 6 d and stained with crystal violet. (E) Cells were photographed under light and fluorescence microscopes on day 2 after plating. (F) Cells were photographed 6 d after replating. (G) RP: colonies of HT-p21 cells treated with IPTG in regular culture or in the presence of HD RPE cells (CI culture), then sorted for GFP and grown in drug-free medium for 12 d.

As shown in Fig. 5 A and B, HT-p21 cells plated alone (regular culture) acquired senescent morphology. In contrast, HT-p21 cells trapped among RPE cells remained small in size. In regular culture of HT-p21 cells (green nucleus), cells remained “red” (pS6-positive cytoplasm). When HT-p21 cells were trapped in the RPE monolayer (Fig. 5A and Fig. S4), all “green” (HT-p21 cells) became pS6-negative (Fig. 5A and Fig. S4).

To measure RP of such cells, IPTG was washed out and cells were replated at LD and allowed to regrow. HT-p21 cells treated with IPTG inside of RPE monolayer retained proliferative potential whereas HT-p21 cells from standard culture did not (Fig. 5C). We conclude that HT-p21 cells inhibited by RPE monolayer did not become senescent. In agreement, they formed large colonies upon replating, whereas HT-p21 cells from regular culture did not (Fig. 5D). To minimize the effect of contaminating RPE cells on colony formation, we next sorted HT-p21 cells from mixed cultures by using GFP marker and replated them at LD in drug-free medium. After attachment, HT-p21 cells from regular culture displayed senescent morphology, whereas the cells from CI culture did not (Fig. 5E). In agreement, CI-culture cells proliferated upon replating and formed colonies, in contrast to HT-p21 cells from regular culture (Fig. 5 F and G).

We also investigated whether CI suppresses senescence caused by PD0332991, an inhibitor of CDK4/6, in normal RPE cells (46). PD0332991 caused morphological senescence in LD cultures, whereby cells were p-S6 positive (Fig. S5). These senescent cells did not restart proliferation when PD0332991 was washed out (Fig. S5). In CI culture, the cells were p-S6 negative (Fig. S5). Despite the treatment with PD0332991, contact inhibited cells did not become senescent and resumed proliferation after replating.

Discussion

Here we confirmed that CI is a reversible type of cell cycle arrest, so that cells can resume proliferation after splitting. We investigated why contact-inhibited cells do not become senescent. We found that CI was associated with deactivation of the mTOR pathway. Previously, we demonstrated that S6 phosphorylation during cell cycle arrest is a marker of senescence and that mTOR is involved in conversion from cell cycle arrest to senescence, a process named geroconversion (47). Serum starvation, rapamycin, and other inhibitors of mTOR prevent geroconversion, sustaining reversible quiescence (6, 7, 9, 45, 48⇓⇓⇓⇓–53). Therefore, inhibition of the mTOR pathway in confluent cultures can explain why cells do not become senescent. Furthermore, the activation of the mTOR pathway in contact-inhibited cells favored senescence. By using several approaches, we demonstrated that CI per se decreased the mTOR activity in normal cells. Conditioning of the medium may further suppress the mTOR pathway, but this is not the primary or predominant mechanism in normal cells. CI by itself potently inhibits the Akt/mTOR pathway. In cancer cells lacking CI, mTOR was still inhibited in high cell density as a result of conditioning/exhaustion of the medium. Remarkably, this inhibition of mTOR the prevented senescence otherwise caused by p21 in low cell densities. Furthermore, the senescent program (i.e., geroconversion) can be suppressed in cancer cells by an artificial CI. To mimic CI, we plated a few cancer cells together with a high number of normal cells. Cancer cells were therefore trapped among contact-inhibited normal cells, or, in other words, were contact-inhibited by normal cells. The mTOR pathway was inhibited in such cells. Induction of p21 did not cause senescence in contact-inhibited cancer cells with deactivated mTOR. Therefore, when mTOR was inhibited by CI, p21-, PD0332991-, or contact-mediated arrest itself was not converted to senescence. The question remains whether senescence induced by irradiation or massive DNA damage would also be ameliorated by confluence, or whether it represent a special case. First, damage can become permanent and could reveal itself upon splitting. Second, induction of DNA damage may by itself modulate the mTOR pathway. For example, radiation strongly induced Akt in murine liver, whereas radiation-induced p53 inhibited mTOR downstream (54). We will investigate this special case of unrepaired DNA damage.

Our present findings have noticeable physiological implications. In the organism, most nonproliferating cells are contact inhibited or at least densely packed. As these conditions cause deactivation of mTOR pathway, cellular senescence is suppressed and the organism may last for decades. On the contrary, suppression of senescence in dense cancer cell cultures may explain why anticancer drugs that easily cause senescence in vitro do not cure cancer in patients. As a special case, solitary cancer cells that are contact-inhibited by normal cells may be resistant to senescence-inducing drugs.

Materials and Methods

Cell Lines and Reagents.

HT-p21 cells, derived from HT1080 human fibrosarcoma cells (American Type Culture Collection), provided by Igor Roninson (University of South Carolina, Charleston, SC), were previously described (5, 43⇓–45). HT-p21 cells were cultured in high-glucose DMEM without pyruvate supplemented with FC2 serum (HyClone FetalClone II; Thermo Scientific). In HT-p21 cells, p21 expression can be turned on or off by using IPTG (43,44). Normal RPE cell lines were obtained from the American Type Culture Collection. RPE cells were maintained in MEM plus 10% (vol/vol) FBS. WI38-tert cells, provided by Eugene Kendal (Roswell Park Cancer Institute, Buffalo, NY) were cultured in low-glucose DMEM plus 10% FBS. NBCs, provided by Jianmin Zhang (Roswell Park Cancer Institute, Buffalo, NY), were cultured in F12K medium plus 10% FBS. Rapamycin was obtained from LC Laboratories. IPTG and etoposide were purchased from Invitrogen and Sigma-Aldrich, respectively.

Immunoblot Analysis.

Whole-cell lysates were prepared by using boiling lysis buffer (1% SDS, 10 mM Tris⋅HCl, pH 74). Equal amounts of proteins were separated by using Criterion or mini gradient polyacrylamide gels (Bio-Rad) and transferred to PVDF membranes. The rabbit antibodies—phospho-S6 (Ser235/236), phospho-AKT (Ser-473), phospho ERK 1/2, and p27—were from Cell Signaling Biotechnology. Mouse anti–phospho-Thr-389 p70S6K and anti-S6 antibody were from Cell Signaling Biotechnology. Rabbit anti-actin antibody was from Sigma-Aldrich; mouse antibodies for p21 and p53 (Ab-6) were from BD Biosciences and Oncogene Research Products, respectively. Secondary anti-rabbit and anti-mouse HRP-conjugated antibodies were from Cell Signaling Biotechnology.

SA-β-Gal Staining.

β-Gal staining was performed by using Senescence-galactosidase staining kit (Cell Signaling Technology) according to the manufacturer’s protocol. Cells were incubated at 37 °C until β-gal staining became visible. Development of color was detected under a light microscope.

Colony Formation Assay.

HT-p21 cells were plated at indicated densities, treated with IPTG for 3–4 d with or without drugs as indicated in the figure legends. Then, drugs were washed off and cells were replated at LD in fresh drug-free medium, and colonies were allowed to grow for a few days (as detailed in the figure legends). Plates were fixed and stained with 1.0% (wt/vol) crystal violet (Sigma-Aldrich). Colonies were counted by using Adobe Photoshop. Indirect immunofluorescence was performed as described previously (48).

Flow Cytometric Analysis of Cell Cycle Distribution.

Cells were fixed in ice-cold 70% (vol/vol) ethanol and stained with propidium iodide. Cell cycle distribution was analyzed using flow cytometry as described previously (48).

Acknowledgments

This work was supported in part by Roswell Park Cancer Institute.

Footnotes

  • ↵1To whom correspondence should be addressed. E-mail: blagosklonny{at}oncotarget.com.
  • Author contributions: O.V.L. and M.V.B. designed research; O.V.L. and Z.N.D. performed research; O.V.L., Z.N.D., and M.V.B. analyzed data; and M.V.B. wrote the paper.

  • The authors declare no conflict of interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1405723111/-/DCSupplemental.

References

  1. ↵
    1. Serrano M,
    2. Lin AW,
    3. McCurrach ME,
    4. Beach D,
    5. Lowe SW
    (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88(5):593–602.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Ferbeyre G,
    2. et al.
    (2002) Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol 22(10):3497–3508.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Blagosklonny MV
    (2003) Cell senescence and hypermitogenic arrest. EMBO Rep 4(4):358–362.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Deng Q,
    2. Liao R,
    3. Wu BL,
    4. Sun P
    (2004) High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J Biol Chem 279(2):1050–1059.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Demidenko ZN,
    2. Blagosklonny MV
    (2008) Growth stimulation leads to cellular senescence when the cell cycle is blocked. Cell Cycle 7(21):3355–3361.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Demidenko ZN,
    2. Korotchkina LG,
    3. Gudkov AV,
    4. Blagosklonny MV
    (2010) Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 107(21):9660–9664.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Leontieva OV,
    2. et al.
    (2012) Hypoxia suppresses conversion from proliferative arrest to cellular senescence. Proc Natl Acad Sci USA 109(33):13314–13318.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Cho S,
    2. Hwang ES
    (2012) Status of mTOR activity may phenotypically differentiate senescence and quiescence. Mol Cells 33(6):597–604.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Kolesnichenko M,
    2. Hong L,
    3. Liao R,
    4. Vogt PK,
    5. Sun P
    (2012) Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. Cell Cycle 11(12):2391–2401.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Leontieva OV,
    2. Demidenko ZN,
    3. Blagosklonny MV
    (2013) MEK drives cyclin D1 hyperelevation during geroconversion. Cell Death Differ 20(9):1241–1249.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Serrano M
    (2012) Dissecting the role of mTOR complexes in cellular senescence. Cell Cycle 11(12):2231–2232.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Blagosklonny MV
    (2012) Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: Terminology for TOR-driven aging. Aging (Albany, NY Online) 4(3):159–165.
    OpenUrl
  13. ↵
    1. Dulic V
    (2013) Senescence regulation by mTOR. Methods Mol Biol 965:15–35.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Levine AJ,
    2. Feng Z,
    3. Mak TW,
    4. You H,
    5. Jin S
    (2006) Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev 20(3):267–275.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Feng Z,
    2. Levine AJ
    (2010) The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein. Trends Cell Biol 20(7):427–434.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Abercrombie M
    (1979) Contact inhibition and malignancy. Nature 281(5729):259–262.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Lloyd RV,
    2. et al.
    (1999) p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol 154(2):313–323.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Leontieva OV,
    2. Blagosklonny MV
    (2011) Yeast-like chronological senescence in mammalian cells: Phenomenon, mechanism and pharmacological suppression. Aging (Albany, NY Online) 3(11):1078–1091.
    OpenUrl
  19. ↵
    1. Krtolica A,
    2. Parrinello S,
    3. Lockett S,
    4. Desprez PY,
    5. Campisi J
    (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging. Proc Natl Acad Sci USA 98(21):12072–12077.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Tchkonia T,
    2. Zhu Y,
    3. van Deursen J,
    4. Campisi J,
    5. Kirkland JL
    (2013) Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest 123(3):966–972.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Pani G
    (2011) From growing to secreting: new roles for mTOR in aging cells. Cell Cycle 10(15):2450–2453.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Knecht E,
    2. Hernández-Yago J,
    3. Grisolía S
    (1984) Regulation of lysosomal autophagy in transformed and non-transformed mouse fibroblasts under several growth conditions. Exp Cell Res 154(1):224–232.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Severino J,
    2. Allen RG,
    3. Balin S,
    4. Balin A,
    5. Cristofalo VJ
    (2000) Is beta-galactosidase staining a marker of senescence in vitro and in vivo? Exp Cell Res 257(1):162–171.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Kurz DJ,
    2. Decary S,
    3. Hong Y,
    4. Erusalimsky JD
    (2000) Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 113(pt 20):3613–3622.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Yang NC,
    2. Hu ML
    (2005) The limitations and validities of senescence associated-beta-galactosidase activity as an aging marker for human foreskin fibroblast Hs68 cells. Exp Gerontol 40(10):813–819.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Gary RK,
    2. Kindell SM
    (2005) Quantitative assay of senescence-associated beta-galactosidase activity in mammalian cell extracts. Anal Biochem 343(2):329–334.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Coates PJ
    (2002) Markers of senescence? J Pathol 196(4):371–373.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Krishna DR,
    2. Sperker B,
    3. Fritz P,
    4. Klotz U
    (1999) Does pH 6 beta-galactosidase activity indicate cell senescence? Mech Ageing Dev 109(2):113–123.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Yegorov YE,
    2. Akimov SS,
    3. Hass R,
    4. Zelenin AV,
    5. Prudovsky IA
    (1998) Endogenous beta-galactosidase activity in continuously nonproliferating cells. Exp Cell Res 243(1):207–211.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Papadopoulos T,
    2. Pfeifer U
    (1987) Protein turnover and cellular autophagy in growing and growth-inhibited 3T3 cells. Exp Cell Res 171(1):110–121.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Lee BY,
    2. et al.
    (2006) Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 5(2):187–195.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Dimri GP,
    2. et al.
    (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92(20):9363–9367.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Blagosklonny MV
    (2013) Hypoxia, MTOR and autophagy: Converging on senescence or quiescence. Autophagy 9(2):260–262.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Chassot AA,
    2. et al.
    (2008) Confluence-induced cell cycle exit involves pre-mitotic CDK inhibition by p27(Kip1) and cyclin D1 downregulation. Cell Cycle 7(13):2038–2046.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Groth A,
    2. Willumsen BM
    (2005) High-density growth arrest in Ras-transformed cells: Low Cdk kinase activities in spite of absence of p27(Kip) Cdk-complexes. Cell Signal 17(9):1063–1073.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Nakayama K,
    2. et al.
    (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85(5):707–720.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Levenberg S,
    2. Yarden A,
    3. Kam Z,
    4. Geiger B
    (1999) p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry. Oncogene 18(4):869–876.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Polyak K,
    2. et al.
    (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 8(1):9–22.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. Seluanov A,
    2. et al.
    (2009) Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat. Proc Natl Acad Sci USA 106(46):19352–19357.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Dietrich C,
    2. Wallenfang K,
    3. Oesch F,
    4. Wieser R
    (1997) Differences in the mechanisms of growth control in contact-inhibited and serum-deprived human fibroblasts. Oncogene 15(22):2743–2747.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Korotchkina LG,
    2. et al.
    (2010) The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany, NY Online) 2(6):344–352.
    OpenUrl
  42. ↵
    1. Leontieva OV,
    2. Blagosklonny MV
    (2012) Hypoxia and gerosuppression: The mTOR saga continues. Cell Cycle 11(21):3926–3931.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Broude EV,
    2. et al.
    (2007) p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene 26(48):6954–6958.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Chang BD,
    2. et al.
    (2000) p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19(17):2165–2170.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Demidenko ZN,
    2. et al.
    (2009) Rapamycin decelerates cellular senescence. Cell Cycle 8(12):1888–1895.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Leontieva OV,
    2. Blagosklonny MV
    (2013) CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion. Cell Cycle 12(18):3063–3069.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Leontieva OV,
    2. Blagosklonny MV
    (2010) DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging (Albany, NY Online) 2(12):924–935.
    OpenUrl
  48. ↵
    1. Leontieva OV,
    2. Lenzo F,
    3. Demidenko ZN,
    4. Blagosklonny MV
    (2012) Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 11(24):4642–4649.
    OpenUrlCrossRefPubMed
  49. ↵
    1. Mercier I,
    2. et al.
    (2012) Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug. Am J Pathol 181(1):278–293.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Iglesias-Bartolome R,
    2. et al.
    (2012) mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 11(3):401–414.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Iglesias-Bartolome R,
    2. Gutkind SJ
    (2012) Exploiting the mTOR paradox for disease prevention. Oncotarget 3(10):1061–1063.
    OpenUrlPubMed
  52. ↵
    1. Hinojosa CA,
    2. et al.
    (2012) Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence. Exp Gerontol 47(12):958–965.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Luo Y,
    2. et al.
    (2014) Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence. Transplantation 97(1):20–29.
    OpenUrlCrossRefPubMed
  54. ↵
    1. Leontieva OV,
    2. et al.
    (2013) Dysregulation of the mTOR pathway in p53-deficient mice. Cancer Biol Ther 14(12):1182–1188.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Contact inhibition suppresses mTOR and senescence
Olga V. Leontieva, Zoya N. Demidenko, Mikhail V. Blagosklonny
Proceedings of the National Academy of Sciences Jun 2014, 111 (24) 8832-8837; DOI: 10.1073/pnas.1405723111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Contact inhibition suppresses mTOR and senescence
Olga V. Leontieva, Zoya N. Demidenko, Mikhail V. Blagosklonny
Proceedings of the National Academy of Sciences Jun 2014, 111 (24) 8832-8837; DOI: 10.1073/pnas.1405723111
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

Article Classifications

  • Biological Sciences
  • Cell Biology
Proceedings of the National Academy of Sciences: 111 (24)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Smoke emanates from Japan’s Fukushima nuclear power plant a few days after tsunami damage
Core Concept: Muography offers a new way to see inside a multitude of objects
Muons penetrate much further than X-rays, they do essentially zero damage, and they are provided for free by the cosmos.
Image credit: Science Source/Digital Globe.
Water from a faucet fills a glass.
News Feature: How “forever chemicals” might impair the immune system
Researchers are exploring whether these ubiquitous fluorinated molecules might worsen infections or hamper vaccine effectiveness.
Image credit: Shutterstock/Dmitry Naumov.
Venus flytrap captures a fly.
Journal Club: Venus flytrap mechanism could shed light on how plants sense touch
One protein seems to play a key role in touch sensitivity for flytraps and other meat-eating plants.
Image credit: Shutterstock/Kuttelvaserova Stuchelova.
Illustration of groups of people chatting
Exploring the length of human conversations
Adam Mastroianni and Daniel Gilbert explore why conversations almost never end when people want them to.
Listen
Past PodcastsSubscribe
Horse fossil
Mounted horseback riding in ancient China
A study uncovers early evidence of equestrianism in ancient China.
Image credit: Jian Ma.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Cozzarelli Prize
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490